NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
Back to search
Official data from USPTO
ACTIM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
02/20/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
06/21/2021
Registration date
10/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FI
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ACTIM" in green within a single line rounded quadrilateral in green. The background of the mark is white.
Holders and representatives
Holders
Actim Oy
Representatives
Roger H. Bora THOMPSON HINE LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations based on immunological methods for medical use; immunological reagent and media for medical purposes; immunological diagnostic testing materials being diagnostic preparations for medical use; immunological diagnostic substances being diagnostic preparations for medical use; immunological diagnostic reagents; immunological diagnostic test strips for use in the field of immunologyanesthesiadermatologyneurologyobstetricsgynecologyreproductive biologybroncologypulmonologyrespiratologyophthalmologyorthopedic surgeryotologylaryngologypathologypediatricsradiologyradiationoncologysurgery; immunological diagnostic testsmedical diagnostic test strips for use in the field of immunologyanesthesiadermatologyneurologyobstetricsgynecologyreproductive biologybroncologypulmonologyrespiratologyophthalmologyorthopedic surgeryotologylaryngologypathologypediatricsradiologyradiationoncologysurgery; all the aforementioned goods excluding for use in hemostasis
Class 10
Medical testing devices utilizing immunological methodsin the form of kits primarily comprised of test strips capable of visual or instrument read out of test resultsbuffer tubesmedical specimen collection loops and vialsfor use in testing of bloodplasmaserumother bodily fluidsalso including cotton swabs and pads for medical purposes; medical diagnostic instruments for in vitro diagnostic testing and in vitro analysis utilizing immunological methods for use in the field of immunologyanesthesiadermatologyneurologyobstetricsgynecologyreproductive biologybroncologypulmonologyrespiratologyophthalmologyorthopedic surgeryotologylaryngologypathologypediatricsradiologyradiationoncologysurgery; all the aforementioned goods excluding for use in hemostasis
Publications
History of USPTO decisions and trademark events.
38 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/30/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/10/2024
FIMP
FINAL DISPOSITION PROCESSED
01/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/20/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/26/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2022
GNRT
NON-FINAL ACTION E-MAILED
11/18/2022
CNRT
NON-FINAL ACTION WRITTEN
11/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2022
RFNT
REFUSAL PROCESSED BY IB
05/25/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/30/2022
RFRR
REFUSAL PROCESSED BY MPU
04/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2022
CNRT
NON-FINAL ACTION WRITTEN
03/20/2022
DOCK
ASSIGNED TO EXAMINER
03/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/25/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/25/2021
Continuous trademark protection
Get notified about every new filing that threatens ACTIM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.